Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Phase I study of Avant's vaccine delivery system shows promising results

Aug. 24, 1999

Dynavax completes patient enrollment and dosing in phase I ragweed allergy trial

Aug. 24, 1999

Xoma and Genentech expand hu1124 collaboration to include transplantation

Aug. 23, 1999

Known anti-HIV compound also shows potential in treating immune disorders

Aug. 20, 1999

SangStat's cold storage solution for donor hearts cleared by FDA

Aug. 19, 1999

New transplant agent marketed by Roche in U.K.

Aug. 18, 1999

Isotechnika advances development of new immunosuppressant

Aug. 17, 1999

Cangene receives notification of fast-track status for new anti-chickenpox product

Aug. 16, 1999

AdProTech reaches C3d adjuvant licensing agreement with University of Cambridge

Aug. 16, 1999

CpG ImmunoPharmaceuticals obtains financing for additional clinical trials

Aug. 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...